Holen Sie sich die Stockscreener-App
1.1999
3.23%
-0.0401
Schlusskurs vom Vortag:
$1.24
Offen:
$1.25
24-Stunden-Volumen:
12,846
Relative Volume:
0.50
Marktkapitalisierung:
$2.15M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-3.11M
KGV:
-0.3002
EPS:
-3.9975
Netto-Cashflow:
$-2.69M
1W Leistung:
+11.10%
1M Leistung:
-6.26%
6M Leistung:
-54.55%
1J Leistung:
-72.22%
1-Tages-Spanne:
$1.1949
$1.25
1-Wochen-Bereich:
$1.08
$1.25
52-Wochen-Spanne:
$1.05
$6.75
Bone Biologics Corp Stock (BBLG) Company Profile
Firmenname
Bone Biologics Corp
Sektor
Branche
Telefon
(781) 552-4452
Adresse
2 BURLINGTON WOODS DRIVE,, BURLINGTON
Compare BBLG vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
1.1999 | 2.23M | 0 | -3.11M | -2.69M | -3.9975 |
VRTX
Vertex Pharmaceuticals Inc
|
433.59 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
762.90 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
747.75 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.75 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
164.04 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Bone Biologics Corp Aktie (BBLG) Neueste Nachrichten
Market Structure, Emerging Trends, and Key Player Analysis in the Orthobiologics Devices and Equipment Sector - openpr.com
Earnings Update: Whats the profit margin of Aptiv PLC2026 Rallies & Capital Protection Trading Alerts - baoquankhu1.vn
Exit Recap: Is Bone Biologics Corporation a strong candidate for buy and holdEarnings Risk Summary & Low Risk Entry Point Guides - baoquankhu1.vn
Global Drivers Analysis: Factors Behind the Rapid Evolution of the Demineralized Bone Matrix Market - openPR.com
Stock List: Research Stocks from Around the World - GuruFocus
Aug PostEarnings: Is INNOVATE Corp a top pick in the sector2026 Valuation Update & Weekly High Conviction Ideas - baoquankhu1.vn
Competitive Analysis: Leading Companies and New Entrants in the Bone Graft Fixation System Market - openPR.com
Gains Report: What is the implied volatility of Bone Biologics Corporation Equity Warrant2026 Selloffs & Capital Protection Trade Alerts - baoquankhu1.vn
Aug Sentiment: Is Bone Biologics Corporation stock a good pick for beginners2026 Analyst Calls & Weekly Top Performers Watchlists - baoquankhu1.vn
Downgrade Watch: Is BCPC likely to announce a buyback2026 Key Highlights & Daily Profit Maximizing Tips - baoquankhu1.vn
If You Invested $1,000 in Bone Biologics Corp (BBLG) - Stock Titan
BBLG Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Market Leaders: Can Bone Biologics Corporation Equity Warrant sustain its profitability2026 Snapshot & Weekly Stock Performance Updates - baoquankhu1.vn
Bone Biologics Corporation Announces $1 Million At-the-Market Offering of Common Stock Through H.C. Wainwright & Co - Minichart
Bone Biologics launches $1.06 million at-the-market offering on Nasdaq - Investing.com
Bone Biologics launches $1.064M at-the-market equity program via H.C. Wainwright - TradingView
Bone Biologics (NASDAQ: BBLG) adds $1.064M at-the-market stock capacity - Stock Titan
Bone Biologics (NASDAQ: BBLG) launches $1.06M ATM sale with Wainwright - Stock Titan
BBLG PE Ratio & Valuation, Is BBLG Overvalued - Intellectia AI
Aug Movers: What is Bone Biologics Corporation Equity Warrant s revenue forecastGlobal Markets & Entry Point Strategy Guides - baoquankhu1.vn
Trading Action: Does NVFY stock benefit from AI growthPortfolio Value Summary & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Treasury Yields: Is InMode Ltd a top pick in the sector2025 Top Decliners & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Surprises Report: Is Bone Biologics Corporation Equity Warrant still a buy after recent gainsJuly 2025 Outlook & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Bone Biologics FY2026 EPS Forecast Reduced by Zacks Research - Defense World
Aug Technicals: What is Bone Biologics Corporations valuation compared to sectorJuly 2025 Catalysts & Trade Opportunity Analysis Reports - baoquankhu1.vn
Brokers Issue Forecasts for Bone Biologics Q1 Earnings - Defense World
Aug Summary: Will IBEX outperform during market rallies2025 Geopolitical Influence & Reliable Price Action Trade Plans - baoquankhu1.vn
BBLG Technical Analysis & Stock Price Forecast - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
BBLG Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BBLG Earnings History & Surprises | EPS & Revenue Results | BONE BIOLOGICS CORP (NASDAQ:BBLG) - ChartMill
getLinesFromResByArray error: size == 0 What sentiment indicators say about Bone Biologics Corporation Equity Warrant stockIndex Update & Reliable Intraday Trade Alerts - mfd.ru
Bone Biologics (NASDAQ: BBLG) flags going concern and limited cash runway - Stock Titan
Bone Biologics 10-K: Operating loss $3.23M, net loss $3.11M; EPS impact noted - TradingView
New fibroblast cell therapy patent targets osteoporosis - Stock Titan
Bone Marrow Aspirate Concentrates Market: Competitive - openPR.com
BBLG Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Stop Loss: Is WULF stock a value trapDip Buying & Stepwise Trade Signal Guides - baoquankhu1.vn
BBLGBone Biologics Corp Latest Stock News & Market Updates - Stock Titan
What is Bone Biologics Corporation’s valuation compared to sectorStock Surge & Verified Momentum Stock Ideas - mfd.ru
IPO Launch: What is Bone Biologics Corporation Equity Warrants market positionJuly 2025 PostEarnings & Low Risk Entry Point Guides - baoquankhu1.vn
Bone Biologics Corp expected to post a loss of 34 cents a shareEarnings Preview - TradingView
Bone Biologics (BBLG) to Release Quarterly Earnings on Wednesday - Defense World
Can Bone Biologics Corporation stock deliver surprise earnings beatWeekly Volume Report & Free Risk Controlled Daily Trade Plans - mfd.ru
Stock Market Recap: How does Universal Corporation compare to its peersInsider Buying & Weekly Momentum Stock Picks - baoquankhu1.vn
NUWE PE Ratio & Valuation, Is NUWE Overvalued - Intellectia AI
Is Bone Biologics Corporation a stock for growth or value investorsWeekly Stock Recap & Growth Oriented Trade Recommendations - mfd.ru
Layoff Tracker: Ultragenyx Downsizes By 10% After Bone Drug’s Phase 3 Fail - BioSpace
Vivex Announces New Peer-Reviewed Publication Demonstrating Long-Term Fusion Outcomes with VIA Form+™ in Lumbar Interbody Fusion - BioSpace
Will Bone Biologics Corporation stock deliver long term returnsJuly 2025 News Drivers & Comprehensive Market Scan Reports - mfd.ru
Finanzdaten der Bone Biologics Corp-Aktie (BBLG)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.90%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):